Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
70 studies found for:    "Localized scleroderma"
Show Display Options
Rank Status Study
1 Unknown  Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Condition: Localized Scleroderma
Interventions: Device: Fractional carbon dioxide laser;   Device: Ultraviolet A1 phototherapy (UVA1)
2 Withdrawn Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
Condition: Morphea
Intervention: Drug: imiquimod 5% cream (Aldara)
3 Terminated Molecular Effects of Topical Calcipotriene on Morphea
Conditions: Morphea;   Localized Scleroderma
Intervention: Drug: topical calcipotriene 0.005% ointment
4 Recruiting Genetic Variants in Linear Localized Scleroderma
Condition: Morphea
Intervention: Other: skin biopsy
5 Completed Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Condition: Symmetric Limited Morphea.
Interventions: Other: Medium Dose UVA-1;   Other: High Dose UVA-1
6 Completed Imiquimod in Children With Plaque Morphea
Condition: Scleroderma, Localized
Intervention: Drug: Imiquimod 5% cream
7 Unknown  Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
Conditions: Scleroderma, Localized;   Morphea;   Scleroderma, Circumscribed
Interventions: Procedure: UVA-1 Phototherapy;   Procedure: Placebo
8 Recruiting Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Conditions: Scleroderma, Localized;   Morphea;   Frontal Linear Scleroderma en Coup de Sabre;   Scleroderma, Circumscribed;   Scleroderma, Linear
Intervention: Other: Morphea
9 Completed Efficacy and Safety of Imatinib in Scleroderma
Conditions: Scleroderma, Localized;   Scleroderma, Systemic
Intervention: Drug: imatinib mesylate
10 Unknown  A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
Condition: Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
Intervention: Drug: Rituximab
11 Withdrawn Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
Condition: Scleroderma
Interventions: Drug: Clobetasol;   Drug: Calcipotriene;   Drug: Tacrolimus
12 Completed Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
Conditions: Keloid;   Scleroderma, Localized;   Acne Keloidalis;   Scars;   Granuloma Annulare
Intervention: Procedure: UVB Irradiation
13 Completed The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
14 Recruiting The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Condition: Scleroderma
Intervention:
15 Recruiting Duke Scleroderma Clinic Patient Registry
Conditions: Scleroderma;   Systemic Sclerosis
Intervention: Other: Registry
16 Recruiting Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Conditions: Scleroderma;   Ssc
Intervention: Other: Occupational therapy treatment
17 Recruiting Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: atorvastatin;   Drug: Placebo
18 Withdrawn Scleroderma Treatment With Celution Processed ADRCs Registry
Condition: Scleroderma
Intervention:
19 Recruiting Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Conditions: SYSTEMIC SCLERODERMA;   ALLOGENEIC MESENCHYMAL STEM CELLS;   ADULT
Intervention: Biological: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
20 Completed Scleroderma ARFI Imaging of the Skin
Condition: Scleroderma
Intervention: Device: ARFI-SVI Ultrasound

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.